Pharmaceutical

Pharmaceutical Technology Excellence Awards 2024: Syngene 

Leading CRDMO Syngene is a Triple Category Award winner in the 2024 Pharmaceutic...

Pharmaceutical Technology Excellence Awards 2024: IFF P...

IFF Pharma Solutions is a winner in the Marketing category in the 2024 Pharmaceu...

Pharmaceutical Technology Excellence Awards 2024: Image...

Image Analysis Group is a winner in the Innovation category in the 2024 Pharmace...

Eli Lilly targets Scorpion Therapeutics to expand reach...

After selling its PI3Kα program to Eli Lilly, Scorpion will spinout out a differ...

FDA CDER director Patrizia Cavazzoni announces resignation

Following a string of FDA resignations, Patrizia Cavazzoni has announced that he...

Alzheimer’s total prevalent cases to reach 22.51 millio...

GlobalData analysis suggests that China will lead with the highest number of pre...

Climb Bio enters licensing deal with Mabworks for CLYM1...

Climb Bio has entered an exclusive licence agreement with Beijing Mabworks Biote...

A2 Biotherapeutics raises $80m to advance CAR-T therapi...

A2 Biotherapeutics has secured $80m in funding to advance its pipeline of CAR-T ...

Light Horse emerges with $62m and Novartis partnership ...

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and hi...

Coave Therapeutics raises $33m in funding to advance AL...

Coave has raised €32m ($33m) in a Series A financing round for advancing its Adv...

Novo Nordisk and Valo expand cardiometabolic drug partn...

Novo Nordisk has expanded its partnership with Valo Health to advance new therap...

Sanofi taps Alloy Therapeutics for CNS antisense drug d...

As part of the agreement, Sanofi will provide Alloy with upfront license fees an...

Clinical trial trends in 2025: Investment headwinds, we...

With clinical trials facing multiple challenges, digital solutions could provide...

MSD’s HPV vaccine gains China NMPA’s expanded approval ...

China's National Medical Products Administration has granted expanded approval t...

Newron and Myung In Pharm sign agreement for evenamide ...

Newron and Myung In Pharm have signed a licence agreement for evenamide, for sch...